Wall Street analyst price targets, ratings consensus & upside potential · Updated May 1, 2026
Last 12 months price action with 12-month analyst target path
As of May 7, 2026, Arhaus, Inc. (ARHS) has a Wall Street consensus price target of $11.17, based on estimates from 14 covering analysts. With the stock currently trading at $7.59, this represents a potential upside of +47.2%. The company has a market capitalization of $661M.
Analyst price targets range from a low of $9.50 to a high of $12.00, representing a 22% spread in expectations. The median target of $12.00 differs from the mean, suggesting potential outlier estimates. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 7 analysts rating the stock as a Buy or Strong Buy,7 rating it Hold, and 0 rating it Sell or Strong Sell. The positive sentiment balance indicates moderate optimism about the stock prospects.
From a valuation perspective, ARHS trades at a trailing P/E of 15.8x and forward P/E of 14.9x. The forward PEG ratio of 0.50 suggests the stock may be undervalued relative to its growth. Analysts expect EPS to grow +7.2% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $14.25, with bear and bull scenarios of $7.20 and $55.71 respectively. Model confidence stands at 50/100, reflecting moderate uncertainty in projections.
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorDCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationSide-by-side business, growth, and profitability comparison vs Amazon.com, Inc..
Start ComparisonQuick answers to the most common questions about buying ARHS stock.
The consensus Wall Street price target for ARHS is $11.17, representing 47.2% upside from the current price of $7.59. With 14 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
ARHS has a consensus rating of "Buy" based on 14 Wall Street analysts. The rating breakdown is mixed, with 7 Hold ratings making up the largest segment. The consensus 12-month price target of $11.17 implies 47.2% upside from current levels.
With a forward P/E of 14.8882x, ARHS trades at a relatively low valuation. The consensus target of $11.17 implies 47.2% appreciation, suggesting meaningful undervaluation.
The most bullish Wall Street analyst has a price target of $12 for ARHS, while the most conservative target is $9.5. The consensus of $11.17 represents the median expectation. Our quantitative valuation model projects a bull case target of $56 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
ARHS is moderately covered, with 14 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 7 have Buy ratings, 7 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month ARHS stock forecast based on 14 Wall Street analysts shows a consensus price target of $11.17, with estimates ranging from $9.5 (bear case) to $12 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $14, with bear/bull scenarios of $7/$56.
Our quantitative valuation model calculates ARHS's fair value at $14 (base case), with a bear case of $7 and bull case of $56. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 50/100.
ARHS trades at a forward P/E ratio of 14.9x based on next-twelve-months earnings estimates compared to a trailing P/E of 15.8x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Wall Street analysts are very optimistic on ARHS, with a "Buy" consensus rating and $11.17 price target (47.2% upside). 7 of 14 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
ARHS analyst price targets range from $9.5 to $12, a 22% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $11.17 consensus represents the middle ground. Our model's $7-$56 range provides an independent fundamental perspective.